L-Cysteine Enzymatic Biocatalysis
Industrial biomanufacturing of high-purity l-cysteine enzymatic biocatalysis utilizing engineered microbial fermentation or biocatalytic enzyme cascades. L-Cysteine HCl monohydrate (food/pharma), L-cysteine base 99%+ — the enzymatic DL-ATC route replaced hair-acid hydrolysis..
1 · What it gives
L-Cysteine Enzymatic Biocatalysis represents a vital sector within modern industrial amino acid and peptide biomanufacturing, replacing petrochemical halogenations and animal tissue hydrolysates with sustainable, highly specific microbial fermentation and enzymatic coupling. By re-engineering central carbon metabolism in Corynebacterium glutamicum, Escherichia coli, or engineered yeasts, metabolic carbon flux is strategically redirected into targeted chiral amino acids, branched-chain analogues, and bioactive oligopeptides with optical purities exceeding 99.8% enantiomeric excess.
The manufacturing platform integrates aerobic submerged fed-batch fermentation in 50–200 m³ bioreactors, automated respiratory-quotient (RQ) carbon feeding, continuous ceramic microfiltration cell separation, and preparative strong-acid cation exchange chromatography. State-of-the-art facilities achieve fermentation titers exceeding 80 g/L with overall downstream recovery yields above 88%. Production satisfies cGMP and food-grade FSSC 22000 standards, ensuring total absence of adventitious microbial contaminants, heavy metals below 5 ppm, and endotoxin levels compliant with parenteral injection monographs.
The key directions of this technology are:
- Metabolic Flux Deregulation in L-Cysteine Enzymatic Biocatalysis: Engineering allosteric point mutations in key feedback-sensitive synthases to permanently unlock end-product inhibition.
- Industrial Fed-Batch Bioprocess Optimization: Coupling dissolved oxygen and exhaust gas mass spectrometry to automated glucose and anhydrous ammonia feeds in 100 m³ vessels.
- Preparative Continuous SMB Ion Exchange: Deploying multi-column simulated moving bed chromatography on sulfonated polystyrene resins for high-capacity desalting.
- Isoelectric Nucleation & Particle Engineering: Utilizing automated anti-solvent cooling crystallization with ultrasonic seed triggering to ensure tight crystal size distribution.
Sectoral value chain#
┌────────────────────────────────────────────────────────┐
│ Tier 1: Carbohydrate Media Thermal Sterilization │
│ (121°C continuous high-temperature short-time HTST) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 2: Submerged Aerobic Fermentation │
│ (50-200 m³ stirred fermenters, automated RQ-feeding) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 3: Continuous Cell Clarification │
│ (Disc-stack centrifugation & 0.1 µm ceramic microfilt)│
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 4: Cation-Exchange Desalting & Carbon Polish │
│ (Sulfonated polystyrene SMB resin & activated carbon) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 5: Isoelectric Crystallization & Fluid-Bed Dry │
│ (Anti-solvent pH-tuned precipitation & vacuum packaging│
└────────────────────────────────────────────────────────┘
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Raw Material Conditioning | Dissolution, filtration, and continuous sterilization (121°C) of industrial glucose syrup and mineral salts. | In: D-glucose starch syrup, ammonium sulfate, mineral salts. Out: Sterile, nutrient-balanced liquid fermentation medium. |
| Aerobic Fed-Batch Cultivation | Multi-stage seed expansion followed by 100 m³ submerged fermentation with exponential ammonia feeding. | In: Inoculum culture, sterile media, ammonia gas, filtered air. Out: High-titer fermentation broth (target active 60-120 g/L). |
| Biomass Clarification | Continuous disc-stack centrifugation and tubular ceramic membrane microfiltration (0.1 µm). | In: Raw fermented broth, flocculant polymers. Out: Crystal-clear cell-free permeate (cell debris completely removed). |
| Ion-Exchange Purification | Selective adsorption of zwitterionic amino acids onto strong cation-exchange resins eluted with ammonia. | In: Acidified permeate, dilute sulfuric acid, ammonia eluent. Out: Desalted, concentrated target amino acid fraction (>95% recovery). |
| Isoelectric Crystallization & Drying | Evaporative vacuum concentration, adjustment to isoelectric point (pI), cooling, and fluid-bed drying. | In: Concentrated eluate, pure HCl/NaOH, anti-solvent. Out: Pure crystalline amino acid active (>99.5% purity, USP/EP grade). |
Cross-cutting technologies of the sector:
- Genome-Scale Metabolic Models (GEM): Predicting optimal metabolic flux distributions and knockout combinations to maximize theoretical yield.
- Tubular Ceramic Microfiltration Elements: High-temperature and chemically resilient zirconia membrane channels ensuring sterile cell-free permeate.
2 · What it replaces 3 · matched by industry
| D3E2 | Biodegradable scrub particles and exfoliants instead of polyethylene microbeads Replaces: Polyethylene (and PP/PET/PMMA) microbeads in rinse-off cosmetics: face/body scrubs, toothpastes, shower gels; glitter (polyester/alu … | COSM |
| D1E– | Biosurfactant and APG cleansing — sophorolipids, rhamnolipids, alkyl polyglucosides — instead of petrochemical SLES/SLS Replaces: Petrochemical anionic surfactants (SLES/SLS) and their ethoxylated feedstock chain (1,4-dioxane contamination risk at trace levels, … | COSM |
| D1E– | Fermentation cosmetic ingredients instead of shark-liver squalene, rooster-comb hyaluronic acid and animal collagen Replaces: Shark-liver oil squalene (deep-sea shark fisheries); hyaluronic acid from rooster combs; bovine/porcine collagen extracts (and their … | COSM |
3 · How to implement 4 steps
- 1
- 2
- 3Purification & downstream
- 4Purification & downstreamBiogas, compost & waste valorisation
4 · Who delivers
Matched suppliers (matched automatically)
| REWOW S.r.l. | Italy | Producer | active |
| Biomatter | Lithuania | Producer | active |
| METGEN | Finland | Producer | active |
| Hofseth Biocare | Norway | Producer | active |
| Noor Enzymes (DWC) LLC | Estonia | Producer | active |
| Enzymaster 酶赛生物 | China | Producer | active |
| Urobo Biotech | South Africa | Producer | active |
| Novonesis | Denmark | Producer | active |
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Novonesis (Novozymes) | 🇩🇰 Denmark | Industrial Enzyme Platforms & Microbial Solutions | Standardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation. | Commercial Scale |
| Codexis | 🇺🇸 United States | CodeEvolver Directed Evolution & API Biocatalysts | Standardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation. | Commercial Scale |
| BASF | 🇩🇪 Germany | Integrated Chemical & Biocatalytic Synthesis | Standardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation. | Commercial Scale |
| Enzymaster | 🇨🇳 China | Engineered Biocatalysts & Chiral Fine Chemicals | Standardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation. | Commercial Scale |
| Lonza | 🇨🇭 Switzerland | Microbial CDMO & Custom Biocatalysis Platforms | Standardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation. | Commercial Scale |
| Evonik Industries | 🇩🇪 Germany | Fermentation Biosurfactants & Specialty Intermediates | Standardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation. | Commercial Scale |
5 · Rules & route to market
declaration (SGR for some categories)
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
USDA BioPreferred, FDA GRAS notifications, USP compendial cGMP standards#
- USDA BioPreferred & NIFA Grants: Federal purchasing preferences and agricultural grant backing for bio-based amino acid manufacturing of L-Cysteine Enzymatic Biocatalysis.
- FDA 21 CFR Part 111 & 211 cGMP Compliance: Stringent quality control for dietary supplements and active pharmaceutical ingredient (API) pathways.
- United States Pharmacopeia (USP) Monograph Verification: Analytical certification of optical purity, heavy metals (<5 ppm), and bacterial endotoxin levels.
European Union
EFSA Novel Food & Feed Additive authorizations, CEP certification, Horizon Europe circular goals#
- EFSA Scientific Opinions on Nutritional Safety: Pre-market safety clearance under Regulation (EC) No 1829/2003 and Regulation (EU) 2015/2283.
- EDQM Certificate of Suitability (CEP): Certification demonstrating compliance with European Pharmacopoeia (Ph. Eur.) monographs for clinical nutrition.
- Zero-Deforestation & Low-Carbon Footprint Verification: Cradle-to-gate life cycle assessments establishing >60% GHG reductions over synthetic petro-chemical routes.
China
14th Five-Year Bioeconomy Strategy, industrial manufacturing bases, National Food Safety Standards#
- National Bioeconomy Strategic Industry: Prioritized scaling of L-半胱氨酸酶法生物催化制造 within world-scale fermentation clusters in Shandong, Hebei, and Ningxia.
- GB 29924 & Pharmacopoeia (ChP) Standards: Rigorous adherence to national food additive specifications and Chinese Pharmacopoeia injectable grades.
- Green Circular Biomanufacturing: Integrated environmental waste-gas recovery and zero-liquid-discharge (ZLD) ammonium salt recycling systems.
6 · Money: tenders & grants
No open tender or grant matched right now.
7 · Tech stack & innovations
- Metabolic Engineering & Host Rewiring in L-Cysteine Enzymatic Biocatalysis:
- Targeted CRISPR-Cas9 disruption of competing catabolic operons in Corynebacterium glutamicum.
- Promoter engineering creating balanced transcriptional cascades driving uninterrupted carbon flux into the target pathway.
- Large-Scale Aerobic Bioreactor Engineering:
- 100,000-liter fermenters equipped with multi-impeller Rushton turbines delivering oxygen transfer rates >150 mmol/L/h.
- Automated exhaust gas mass spectrometry providing real-time respiratory quotient (RQ) feedback to modulate sugar feeds.
- Continuous Simulated Moving Bed (SMB) Downstream:
- Counter-current carousel ion-exchange chromatography systems separating amino acid zwitterions with >98% recovery.
- Programmed isoelectric cooling crystallization with ultrasonic seed generation ensuring uniform 150-250 µm crystal morphology.
Sources 2 · 2 independent · 0 producer sites
Independent sources 2
- www.ncbi.nlm.nih.gov research checked 2026-11-15
- doi.org research checked 2026-11-15